Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-05 12:10 pm Purchase | 2026-06-30 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | PRINCIPAL GLOBAL INVESTORS | 1,632,360 5.000% | 165,854![]() (+11.31%) | Filing History |
| 2026-07-31 09:54 am Purchase | 2026-06-30 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Vanguard Capital Management | 1,625,821 5.010% | 1,625,821![]() (New Position) | Filing History |
| 2026-05-15 11:42 am Purchase | 2026-03-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | JANUS HENDERSON GROUP Ltd. JHG | 1,825,651 5.800% | 344,481![]() (+23.26%) | Filing History |
| 2026-05-15 11:33 am Sale | 2026-03-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Eventide Asset Management, LLC | 1,424,282 4.500% | -451,957![]() (-24.09%) | Filing History |
| 2026-05-14 4:44 pm Sale | 2026-01-08 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Renaissance Technologies LLC | 1,469,449 4.530% | -129,740![]() (-8.11%) | Filing History |
| 2026-05-12 5:55 pm Purchase | 2026-05-07 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Integrated Core Strategies (US) LLC | 1,519,500 4.700% | 1,519,500![]() (New Position) | Filing History |
| 2026-05-08 10:17 am Purchase | 2026-03-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Invesco Ltd. IVZ | 1,591,909 5.000% | 7,038![]() (+0.44%) | Filing History |
| 2026-03-26 5:43 pm Sale | 2026-03-13 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | VANGUARD GROUP INC | 0 0.000% | -2,312,786![]() (Position Closed) | Filing History |
| 2026-02-13 4:05 pm Sale | 2025-12-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Rubric Capital Management LP | 1,496,436 4.730% | -1,503,564![]() (-50.12%) | Filing History |
| 2026-02-13 12:51 pm Sale | 2025-12-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Eventide Asset Management, LLC | 1,876,239 5.900% | -754,239![]() (-28.67%) | Filing History |
| 2025-11-13 2:26 pm Purchase | 2025-09-08 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Renaissance Technologies LLC | 1,599,189 5.060% | 78,019![]() (+5.13%) | Filing History |
| 2025-08-13 4:05 pm Sale | 2025-04-01 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Renaissance Technologies LLC | 1,521,170 4.820% | -134,899![]() (-8.15%) | Filing History |
| 2025-08-11 4:49 pm Sale | 2025-06-30 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | PRINCIPAL GLOBAL INVESTORS | 1,466,506 4.600% | -279,157![]() (-15.99%) | Filing History |
| 2025-08-07 4:27 pm Sale | 2025-06-30 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Invesco Ltd. IVZ | 1,584,871 4.900% | -190,889![]() (-10.75%) | Filing History |
| 2025-05-14 4:04 pm Purchase | 2025-03-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Rubric Capital Management LP | 3,000,000 9.340% | 650,000![]() (+27.66%) | Filing History |
| 2025-05-02 11:04 am Sale | 2025-03-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Pacer Advisors Inc. | 419,076 1.060% | -1,723,415![]() (-80.44%) | Filing History |
| 2025-05-02 10:33 am Purchase | 2024-12-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Pacer Advisors Inc. | 2,142,491 5.400% | 2,142,491![]() (New Position) | Filing History |
| 2025-04-28 07:56 am Sale | 2025-03-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | BlackRock Inc. BLK | 4,997,827 15.600% | -788,700![]() (-13.63%) | Filing History |
| 2025-02-13 4:01 pm Purchase | 2024-12-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Rubric Capital Management LP | 2,350,000 7.290% | 1,100,000![]() (+88.00%) | Filing History |
| 2025-02-07 1:21 pm Purchase | 2024-12-31 | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Invesco Ltd. IVZ | 1,775,760 5.500% | 1,775,760![]() (New Position) | Filing History |

